Pfizer-BioNTech and Moderna expand studies of children 5 to 11

At the urging of federal regulators, two coronavirus vaccine makers are expanding the size of their studies in children ages 5 to 11 — a precautionary measure designed to detect rare side effects including heart inflammation problems that turned up in vaccinated people younger than 30.

from bdnews24.com - Home https://ift.tt/3x6reIT